Far fewer U.S. men are being diagnosed with early stage prostate cancer and getting blood tests to detect the disease since an influential government-appointed panel recommended against routine screening of all men, an American Cancer Society study found.
A big question remains: Did that shift have any effect on death rates from prostate cancer, the most common non-skin cancer in U.S. men? About one in seven U.S. men will be diagnosed with the disease in their lifetimes. While most will die from something else, more than 27,000 are expected to die from the disease this year alone.
Less Prostate Cancer and Screening Seen After New Guidance - NBC News